China Adds Second GLP-1 Diabetes Drug to Essential Medicine List
China will add a second GLP-1 drug, used to treat diabetes, to a list of essential drugs all public hospitals are required to prioritise having in their formulary, a... Reuters Health Information
Read the full articleYou might also wanna read
GLP-1 Agonists May Help People With Diabetes and Long COVID
People with type 2 diabetes face increased risk of severe lung conditions. A new study reported that mice treated with GLP-1agonists showed
Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock.
Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
In this week’s Optimizer, we take a look at how health tech companies are starting to incorporate features ‘built for GLP-1’ users.
theverge.com·1mo ago
FDA Announces Plans to Restrict Non-Approved GLP-1 Drugs in Compounded Medications
Today, the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredi
fda.gov·5mo agoGLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Conditions : Alzheimer Disease; Diabetes Mellitus Type 2; Obesity & Overweight Interventions : Drug: GLP-1 Receptor Agonists; Drug: DPP-4 In
Kailera’s oral GLP-1 asset sees 11% weight loss, hits goals in Chinese phase 3 obesity and diabetes trials
Phase 3 trials of Kailera Therapeutics’ oral GLP-1 prospect have hit their primary endpoints, positioning the biotech’s partner Hengrui Phar
Comments
Sign in to join the conversation.
No comments yet. Be the first.